Financhill
Sell
19

GMAB Quote, Financials, Valuation and Earnings

Last price:
$20.31
Seasonality move :
3.07%
Day range:
$20.13 - $20.43
52-week range:
$19.85 - $32.88
Dividend yield:
0%
P/E ratio:
19.29x
P/S ratio:
4.58x
P/B ratio:
2.70x
Volume:
1.8M
Avg. volume:
1.3M
1-year change:
-33.56%
Market cap:
$12.9B
Revenue:
$2.4B
EPS (TTM):
$1.05

Earnings Data

Next earnings date for GMAB
May 08
2025
Most recent earnings per share
$0.29
Missed by $0.04
(Nov 6/2024)
Consensus Estimate
$0.33
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GMAB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 $893.6M -- -- $0.39 --
11/06/2024 Q3 $819.2M $816.4M $0.29 $0.33 -$0.04
08/08/2024 Q2 $723.6M $779.7M $0.31 $0.28 $0.03
05/02/2024 Q1 $572.3M $603.5M $0.29 $0.18 $0.11
02/14/2024 Q4 $667.6M $686.8M $0.15 $0.28 -$0.13
11/07/2023 Q3 -- -- $0.47 $0.29 $0.18
08/03/2023 Q2 -- -- $0.30 $0.23 $0.07
05/10/2023 Q1 -- -- $0.05 $0.16 -$0.11
12/31/2022 Q4 -- -- $0.11 $0.34 -$0.24
11/09/2022 Q3 -- -- $0.53 $0.22 $0.31
08/10/2022 Q2 -- -- $0.41 $0.22 $0.19
05/11/2022 Q1 -- -- $0.11 -- --
02/16/2022 Q4 -- -- $0.15 -- --
11/10/2021 Q3 -- -- $0.21 -- --
08/11/2021 Q2 -- -- $0.08 -- --
05/05/2021 Q1 -- -- $0.27 -- --
02/23/2021 Q4 -- -- $0.14 -- --
11/04/2020 Q3 -- -- $0.13 -- --
08/12/2020 Q2 -- -- $0.76 -- --
05/06/2020 Q1 -- -- $0.06 -- --
02/19/2020 Q4 -- -- $0.34 -- --
11/06/2019 Q3 -- -- $0.12 -- --
08/14/2019 Q2 -- -- $0.02 -- --
03/31/2019 Q1 -- -- $0.02 -- --
12/31/2018 Q4 -- -- $0.21 -- --
09/30/2018 Q3 -- -- $0.05 -- --
06/30/2018 Q2 -- -- $0.07 -- --
03/31/2018 Q1 -- -- $0.05 -- --
12/31/2017 Q4 -- -- $0.20 -- --
09/30/2017 Q3 -- -- -$0.00 -- --
06/30/2017 Q2 -- -- $0.07 -- --
03/31/2017 Q1 -- -- $0.00 -- --
12/31/2016 Q4 -- -- $0.20 -- --
09/30/2016 Q3 -- -- $0.05 -- --
06/30/2016 Q2 -- -- $0.04 -- --
03/31/2016 Q1 -- -- -$0.00 -- --
12/31/2015 Q4 -- -- $0.09 -- --
09/30/2015 Q3 -- -- $0.03 -- --
06/30/2015 Q2 -- -- $0.00 -- --
03/31/2015 Q1 -- -- $0.06 -- --
12/31/2014 Q4 -- -- $0.02 -- --

Genmab AS Earnings Questions

  • How Much did Genmab AS Generate in Revenue Last Quarter?

    Genmab AS reported $816.4M worth of top line sales in its most recent quarter.

  • Did Genmab AS Beat Earnings Last Quarter?

    Genmab AS announced earnings per share of $0.29 which represents a miss of analyst forecast a $0.33 per share.

  • Is Genmab AS Profitable?

    Genmab AS reported $776.2M that represents $1.21 per share over the last quarter.

  • What is the Analyst Consensus for Genmab AS EPS Next Year?

    Genmab AS's earnings are forecast to grow from $0.96 per share to $1.14 per share next year representing an increase of 35.2%.

  • When is Genmab AS's Earnings Date?

    Genmab AS's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock